While traditional induction therapy for newly diagnosed stage 2 myeloma often focuses on combinations of proteasome inhibitors, immunomodulatory drugs, and steroids, these newer immunotherapy classes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback